pd 169316 has been researched along with Idiopathic Parkinson Disease in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, CK | 1 |
| Han, BS | 1 |
| Choi, WS | 1 |
| Youdim, MB | 1 |
| Oh, YJ | 1 |
1 other study available for pd 169316 and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 2; Caspase Inhibitors; Cell Line; Cytochrome | 2011 |